Literature DB >> 568220

Induction of lysosomal storage by suramin.

C H Buys, J M Bouma, M Gruber, E Wisse.   

Abstract

Isolated livers of rats injected with saline or with suramin (250 mg per kg body weight) 24h previously were perfused with a medium containing radioactively labeled formaldehyde-treated albumin. Suramin-loaded livers released breakdown products at a much lower rate than controls and contained about the double amount of undigested radioactive protein up to about 3 h after the start of the perfusion. These results show that inhibition of proteolysis by suramin as reported previously (Davies et al., 1971; Buys et al., 1973) is not caused by binding of the drug to the substrate in the bloodstream. Electron micrographs of liver sections of suramin-treated rats showed that lysosomes of sinusoidal cells resembled those seen in certain lysosomal storage diseases. The effect of suramin on lysosomal enzymes was studied in vitro. When used at a concentration corresponding to the putative concentration in lysosomes in vivo, the drug inhibited the lysosomal endopeptidases cathepsin Bl and D as well as acid phosphatase. Inhibition of acid phosphatase by suramin in vivo could also be demonstrated by histochemical methods. These results suggest that the observed storage phenomena may be mainly caused by inhibition of lysosomal enzymes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 568220     DOI: 10.1007/bf00495555

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  41 in total

1.  Distribution of lysosomal enzymes in different types of rat liver cells.

Authors:  A C Munthe-Kaas; T Berg; R Seljelid
Journal:  Exp Cell Res       Date:  1976-04       Impact factor: 3.905

2.  The sodium-stimulated adenosine-triphosphatase activity and other properties of cerebral microsomal fractions and subfractions.

Authors:  A SCHWARTZ; H S BACHELARD; H McIL WAIN
Journal:  Biochem J       Date:  1962-09       Impact factor: 3.857

3.  Catabolism of plasma albumin by the perfused rat liver.

Authors:  S COHEN; A H GORDON
Journal:  Biochem J       Date:  1958-12       Impact factor: 3.857

4.  The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other diseases.

Authors:  J A GOLDBARG; A M RUTENBURG
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

5.  A modified ninhydrin reagent for the photometric determination of amino acids and related compounds.

Authors:  S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

6.  Studies on Bayer 205 (Germanin) and Antrypol: The retention of the drug in the animal body.

Authors:  J C Boursnell; A Wormall
Journal:  Biochem J       Date:  1939-08       Impact factor: 3.857

7.  Studies on suramin; the action of the drug on some enzymes.

Authors:  E D WILLS; A WORMALL
Journal:  Biochem J       Date:  1950-08       Impact factor: 3.857

8.  The digestion of the B chain of oxidised insulin by extracts of rat liver lysosomes.

Authors:  K D Kussendrager; Y de Jong; J M Bouma; M Gruber
Journal:  Biochim Biophys Acta       Date:  1972-08-18

9.  THE ESTIMATION OF PEPSIN, TRYPSIN, PAPAIN, AND CATHEPSIN WITH HEMOGLOBIN.

Authors:  M L Anson
Journal:  J Gen Physiol       Date:  1938-09-20       Impact factor: 4.086

10.  Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study.

Authors:  A Blouin; R P Bolender; E R Weibel
Journal:  J Cell Biol       Date:  1977-02       Impact factor: 10.539

View more
  10 in total

1.  Suramin-induced storage disease. Mucopolysaccharidosis.

Authors:  G Constantopoulos; S Rees; B G Cragg; J A Barranger; R O Brady
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

2.  Inhibition of immune complex-mediated activation of complement. Effects of agents modulating activation of, and the activated C1 complex.

Authors:  D S Fletcher; T Y Lin
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

3.  The effect of chloroquine on lysosomal function and cell-coat glycoprotein transport in the absorptive cells of cultured human small-intestinal tissue.

Authors:  J Blok; A A Mulder-Stapel; L A Ginsel; W T Daems
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

4.  Endocytosis and breakdown of mitochondrial malate dehydrogenase in the rat in vivo. Effects of suramin and leupeptin.

Authors:  M K Bijsterbosch; A M Duursma; J M Bouma; M Gruber
Journal:  Biochem J       Date:  1982-10-15       Impact factor: 3.857

5.  Endocytosis and breakdown of 125I-labelled lactate dehydrogenase isoenzyme M4 by rat liver and spleen in vivo.

Authors:  J Sinke; J M Bouma; T Kooistra; M Gruber
Journal:  Biochem J       Date:  1979-04-15       Impact factor: 3.857

6.  Perhexiline maleate toxicity on human liver cell lines.

Authors:  J Y Le Gall; A Guillouzo; D Glaise; Y Deugnier; M Messner; M Bourel
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

7.  Suramin-induced mucopolysaccharidosis in rat incisor.

Authors:  A Gritli; D Septier; M Goldberg
Journal:  Cell Tissue Res       Date:  1993-07       Impact factor: 5.249

8.  Organomegaly and histopathology in an animal model of mucopolysaccharidosis induced by suramin.

Authors:  S Rees; G Constantopoulos; J A Barranger; R O Brady
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

9.  Insulin secretion and islet lysosomal enzyme activities in the mouse. Effects of suramin.

Authors:  G Skoglund; B Ahrén; I Lundquist
Journal:  Int J Pancreatol       Date:  1989-02

10.  On the alcianophilia of the drug suramin used as a tool for inducing experimental mucopolysaccharidosis.

Authors:  B Christensen; R Lüllmann-Rauch
Journal:  Histochemistry       Date:  1988
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.